CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Delcath Systems, Inc. - DCTH CFD

2.74
3.86%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.04
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.85
Open* 2.81
1-Year Change* -3.77%
Day's Range* 2.72 - 2.85
52 wk Range 2.25-7.99
Average Volume (10 days) 668.87K
Average Volume (3 months) 8.67M
Market Cap 65.26M
P/E Ratio -100.00K
Shares Outstanding 22.05M
Revenue 2.17M
EPS -3.52
Dividend (Yield %) N/A
Beta 0.51
Next Earnings Date Mar 25, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 1, 2023 2.85 0.15 5.56% 2.70 2.88 2.68
Nov 30, 2023 2.72 -0.04 -1.45% 2.76 2.88 2.70
Nov 29, 2023 2.78 -0.08 -2.80% 2.86 2.91 2.78
Nov 28, 2023 2.83 -0.14 -4.71% 2.97 2.97 2.79
Nov 27, 2023 2.96 0.02 0.68% 2.94 3.10 2.93
Nov 24, 2023 2.98 0.11 3.83% 2.87 2.99 2.84
Nov 22, 2023 2.88 -0.11 -3.68% 2.99 3.07 2.85
Nov 21, 2023 2.95 0.03 1.03% 2.92 3.03 2.71
Nov 20, 2023 2.67 0.19 7.66% 2.48 2.83 2.44
Nov 17, 2023 2.42 -0.05 -2.02% 2.47 2.52 2.36
Nov 16, 2023 2.46 0.10 4.24% 2.36 2.50 2.35
Nov 15, 2023 2.37 0.08 3.49% 2.29 2.59 2.29
Nov 14, 2023 2.30 -0.60 -20.69% 2.90 2.95 2.30
Nov 13, 2023 2.96 0.09 3.14% 2.87 3.03 2.87
Nov 10, 2023 2.93 -0.01 -0.34% 2.94 3.00 2.86
Nov 9, 2023 2.97 -0.13 -4.19% 3.10 3.12 2.89
Nov 8, 2023 3.13 -0.07 -2.19% 3.20 3.25 3.10
Nov 7, 2023 3.22 0.03 0.94% 3.19 3.27 3.10
Nov 6, 2023 3.17 0.10 3.26% 3.07 3.25 3.07
Nov 3, 2023 3.11 -0.09 -2.81% 3.20 3.30 3.01

Delcath Systems, Inc. Events

Time (UTC) Country Event
Monday, March 25, 2024

Time (UTC)

12:30

Country

US

Event

Q4 2023 Delcath Systems Inc Earnings Release
Q4 2023 Delcath Systems Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2.719 3.555 1.646 1.58 3.407
Revenue 2.719 3.555 1.646 1.58 3.407
Cost of Revenue, Total 0.686 0.671 0.64 0.719 1.009
Gross Profit 2.033 2.884 1.006 0.861 2.398
Total Operating Expense 36.572 28.086 22.949 21.488 31.601
Selling/General/Admin. Expenses, Total 16.103 13.637 11.108 11.279 9.819
Research & Development 18.583 13.778 11.201 9.49 19.65
Operating Income -33.853 -24.531 -21.303 -19.908 -28.194
Interest Income (Expense), Net Non-Operating -2.685 -1.186 -3.007 11.027 8.921
Other, Net 0.03 0.068 0.154 0.002 0.051
Net Income Before Taxes -36.508 -25.649 -24.156 -8.879 -19.222
Net Income After Taxes -36.508 -25.649 -24.156 -8.879 -19.222
Net Income Before Extra. Items -36.508 -25.649 -24.156 -8.879 -19.222
Net Income -36.508 -25.649 -24.156 -8.879 -19.222
Total Adjustments to Net Income 0 -0.055 0
Income Available to Common Excl. Extra. Items -36.508 -25.649 -24.211 -8.879 -19.222
Income Available to Common Incl. Extra. Items -36.508 -25.649 -24.211 -8.879 -19.222
Diluted Net Income -36.508 -25.649 -24.211 -8.879 -19.222
Diluted Weighted Average Shares 8.86462 7.14575 2.89783 0.0259 0.03819
Diluted EPS Excluding Extraordinary Items -4.1184 -3.5894 -8.35488 -342.819 -503.343
Diluted Normalized EPS -3.98303 -3.5894 -8.35488 -342.819 -473.936
Unusual Expense (Income) 1.2 0 1.123
Total Extraordinary Items
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0.495 0.597 0.639 0.906 0.797
Revenue 0.495 0.597 0.639 0.906 0.797
Cost of Revenue, Total 0.15 0.181 0.237 0.235 0.18
Gross Profit 0.345 0.416 0.402 0.671 0.617
Total Operating Expense 8.492 8.922 10.165 8.707 10.283
Selling/General/Admin. Expenses, Total 4.787 4.165 4.994 3.319 4.497
Research & Development 3.555 4.576 4.934 3.953 5.606
Operating Income -7.997 -8.325 -9.526 -7.801 -9.486
Interest Income (Expense), Net Non-Operating 0.789 -0.688 -0.645 -0.73 -0.665
Other, Net 0.006 0.013 0.028 0.026 -0.008
Net Income Before Taxes -7.202 -9 -10.143 -8.505 -10.159
Net Income After Taxes -7.202 -9 -10.143 -8.505 -10.159
Net Income Before Extra. Items -7.202 -9 -10.143 -8.505 -10.159
Net Income -7.202 -9 -10.143 -8.505 -10.159
Income Available to Common Excl. Extra. Items -7.202 -9 -10.143 -8.505 -10.159
Income Available to Common Incl. Extra. Items -7.202 -9 -10.143 -8.505 -10.159
Diluted Net Income -7.202 -9 -10.143 -8.505 -10.159
Diluted Weighted Average Shares 12.4637 11.6224 9.85044 9.21579 8.19048
Diluted EPS Excluding Extraordinary Items -0.57784 -0.77437 -1.0297 -0.92287 -1.24034
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.57784 -0.77437 -1.0297 -0.79266 -1.24034
Total Adjustments to Net Income
Unusual Expense (Income) 0 1.2
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 16.155 31.152 32.338 12.617 5.919
Cash and Short Term Investments 7.671 22.802 28.575 10.002 2.516
Cash & Equivalents 7.671 22.802 28.575 10.002 2.516
Total Receivables, Net 0.366 0.044 0.057 0.021 1.164
Accounts Receivable - Trade, Net 0.366 0.044 0.057 0.021 0.585
Total Inventory 1.998 1.412 0.855 0.654 0.858
Other Current Assets, Total 4.369 5.264 0.181 0.181 1.381
Total Assets 17.862 33.124 34.635 14.212 6.844
Property/Plant/Equipment, Total - Net 1.707 1.972 2.297 1.595 0.925
Property/Plant/Equipment, Total - Gross 6.638 6.797 5.232
Accumulated Depreciation, Total -4.931 -4.825 -4.307
Total Current Liabilities 14.735 5.954 10.035 15.994 17.75
Accounts Payable 2.018 0.638 1.774 4.533 7.715
Accrued Expenses 4.871 3.974 5.736 7.611 3.434
Notes Payable/Short Term Debt 0 0.551 0 0 0
Current Port. of LT Debt/Capital Leases 7.846 0.621 2 0 2.038
Other Current Liabilities, Total 0 0.17 0.525 3.85 4.563
Total Liabilities 23.721 21.172 12.557 20.569 21.783
Total Long Term Debt 7.842 15.011 0 2 0
Other Liabilities, Total 1.144 0.207 2.522 2.575 4.033
Total Equity -5.859 11.952 22.078 -6.357 -14.939
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.1 0.079 0.06 0.001 0.103
Additional Paid-In Capital 451.608 432.831 417.449 364.785 328.962
Retained Earnings (Accumulated Deficit) -457.484 -420.976 -395.327 -371.171 -344.054
Treasury Stock - Common 0
Other Equity, Total -0.083 0.018 -0.104 0.028 0.05
Total Liabilities & Shareholders’ Equity 17.862 33.124 34.635 14.212 6.844
Total Common Shares Outstanding 10.0466 7.90673 5.9961 0.06709 0.01463
Prepaid Expenses 1.751 1.63 2.67 1.759
Other Long Term Assets, Total 0
Long Term Debt 7.842 15.011 0 2
Total Preferred Shares Outstanding 0.01136 0.01136
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 46.096 19.472 29.022 16.155 18.48
Cash and Short Term Investments 40.462 14.54 24.222 7.671 9.831
Cash & Equivalents 40.462 14.54 24.222 7.671 9.831
Total Receivables, Net 0.205 0.127 0.458 0.366 0.537
Accounts Receivable - Trade, Net 0.205 0.127 0.458 0.366 0.537
Total Inventory 2.667 2.48 2.337 1.998 1.926
Prepaid Expenses 2.285 2.019 1.721 1.751 1.84
Other Current Assets, Total 0.477 0.306 0.284 4.369 4.346
Total Assets 47.577 21.05 30.599 17.862 20.226
Property/Plant/Equipment, Total - Net 1.481 1.578 1.577 1.707 1.746
Property/Plant/Equipment, Total - Gross 6.498 6.577 6.547 6.638 6.609
Accumulated Depreciation, Total -5.017 -4.999 -4.97 -4.931 -4.863
Total Current Liabilities 13.974 11.114 13.411 14.735 14.446
Accounts Payable 0.753 0.966 2.428 2.018 2.632
Accrued Expenses 5.265 5.638 7.213 4.871 5.333
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.956 4.51 3.77 7.846 6.481
Other Current Liabilities, Total 0 0
Total Liabilities 22.858 21.292 25.307 23.721 25.472
Total Long Term Debt 2 5.252 5.798 7.842 9.727
Other Liabilities, Total 6.884 4.926 6.098 1.144 1.299
Total Equity 24.719 -0.242 5.292 -5.859 -5.246
Common Stock 0.197 0.153 0.101 0.1 0.086
Additional Paid-In Capital 518.607 473.355 453.37 451.608 442.066
Retained Earnings (Accumulated Deficit) -494.026 -473.686 -466.483 -457.484 -447.341
Other Equity, Total -0.059 -0.064 -0.064 -0.083 -0.057
Total Liabilities & Shareholders’ Equity 47.577 21.05 30.599 17.862 20.226
Total Common Shares Outstanding 19.689 15.2505 10.0816 10.0466 8.59768
Long Term Debt 2 5.252 5.798 7.842 9.727
Preferred Stock - Non Redeemable, Net 0 0 18.368 0 0
Total Preferred Shares Outstanding 0.03779 0.02098 0.01136 0.01136 0.01136
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -36.508 -25.649 -24.156 -8.879 -19.222
Cash From Operating Activities -24.95 -22.604 -22.868 -23.69 -14.732
Cash From Operating Activities 0.132 0.146 0.167 0.212 0.444
Non-Cash Items 9.312 8.663 6.927 -7.92 -7.726
Changes in Working Capital 2.114 -5.764 -5.806 -7.103 11.772
Cash From Investing Activities -0.209 -0.143 -0.782 -0.024 -0.076
Capital Expenditures -0.209 -0.143 -0.782 -0.024 -0.076
Other Investing Cash Flow Items, Total
Cash From Financing Activities 10.143 20.822 42.355 30.305 13.236
Financing Cash Flow Items 0 -0.107 26.475 0
Issuance (Retirement) of Stock, Net 10.857 6.385 42.488 0.15 12.442
Issuance (Retirement) of Debt, Net -0.714 14.437 -0.026 3.68 0.794
Foreign Exchange Effects -0.115 0.122 -0.132 0.014 -0.174
Net Change in Cash -15.131 -1.803 18.573 6.605 -1.746
Cash Interest Paid 1.873 0.681 0.011
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -9 -36.508 -26.365 -17.86 -8.203
Cash From Operating Activities -4.264 -24.95 -17.591 -12.412 -6.375
Cash From Operating Activities 0.03 0.132 0.098 0.031 0.031
Non-Cash Items 1.982 9.312 5.378 3.785 1.805
Cash Interest Paid 0.491 1.873 1.337 0.842 0.411
Changes in Working Capital 2.724 2.114 3.298 1.632 -0.008
Cash From Investing Activities 0 -0.209 -0.209 -0.141 -0.089
Capital Expenditures 0 -0.209 -0.209 -0.141 -0.089
Cash From Financing Activities 16.694 10.143 4.896 0 0
Issuance (Retirement) of Stock, Net 23.007 10.857 4.896 0 0
Issuance (Retirement) of Debt, Net -6.313 -0.714 0
Foreign Exchange Effects 0.02 -0.115 -0.067 -0.046 0.002
Net Change in Cash 12.45 -15.131 -12.971 -12.599 -6.462
Financing Cash Flow Items
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Vivo Capital, LLC Venture Capital 7.7163 1178787 1178787 2023-06-30 LOW
BVF Partners L.P. Hedge Fund 7.7163 1178787 1178787 2023-06-30 LOW
Logos Global Management LLC Investment Advisor 7.7163 1178787 1178787 2023-06-30 HIGH
Soleus Capital Management, L.P. Hedge Fund 5.2788 806420 806420 2023-08-15 HIGH
Rosalind Advisors, Inc. Hedge Fund 3.0067 459315 59315 2022-12-21 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.545 388789 18463 2023-06-30 LOW
Stonepine Capital Management, LLC Investment Advisor/Hedge Fund 2.4795 378787 378787 2023-06-30 HIGH
Michel (Gerard J) Individual Investor 1.4947 228345 31110 2023-08-18 LOW
Kent Lake Capital LLC Hedge Fund 1.4366 219468 0 2023-06-30 HIGH
EAM Investors, LLC Investment Advisor/Hedge Fund 1.0165 155280 155280 2023-06-30 HIGH
CIBC World Markets Inc. Research Firm 0.8164 124717 21885 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7628 116536 53803 2023-06-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.3988 60926 17115 2023-06-30 LOW
Salamon (Steven A. J.) Individual Investor 0.3621 55315 0 2023-04-20 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2992 45703 30178 2023-06-30 LOW
Purpura (John) Individual Investor 0.2718 41526 14505 2023-10-13 LOW
Advisors Capital Management, LLC Investment Advisor 0.1769 27021 0 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1752 26757 0 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 0.1407 21500 9400 2023-06-30 HIGH
Citadel Advisors LLC Hedge Fund 0.1203 18373 18373 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Delcath Systems, Inc. Company profile

About Delcath Systems Inc

Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.

Equity composition

Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.

Industry: Medical Prosthetics

1633 Broadway Ste 22C
NEW YORK
NEW YORK 10019-6708
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

Gold

2,035.03 Price
-1.780% 1D Chg, %
Long position overnight fee -0.0200%
Short position overnight fee 0.0118%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

73.34 Price
-1.600% 1D Chg, %
Long position overnight fee -0.0200%
Short position overnight fee -0.0019%
Overnight fee time 22:00 (UTC)
Spread 0.040

US100

15,803.70 Price
-1.150% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.62 Price
-0.410% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading